Verma S - Search Results

1

Psychological and genetic counseling implications for adolescent daughters of mothers with breast cancer.

Cappelli M, Verma S, Korneluk Y, Hunter A, Tomiak E, Allanson J, DeGrasse C, Corsini L, Humphreys L. Cappelli M, et al. Among authors: verma s. Clin Genet. 2005 Jun;67(6):481-91. doi: 10.1111/j.1399-0004.2005.00456.x. Clin Genet. 2005. PMID: 15857415

2

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.

Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J. Cappelli M, et al. Among authors: verma s. Clin Genet. 1999 Jun;55(6):419-30. doi: 10.1034/j.1399-0004.1999.550605.x. Clin Genet. 1999. PMID: 10450858

3

Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing.

Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J. Cappelli M, et al. Among authors: verma s. Qual Life Res. 2001;10(7):595-607. doi: 10.1023/a:1013123915272. Qual Life Res. 2001. PMID: 11822793

4

Living with the BRCA1 and BRCA2 genetic mutation: learning how to adapt to a virtual chronic illness.

Samson A, DiMillo J, Thériault A, Lowry S, Corsini L, Verma S, Tomiak E. Samson A, et al. Among authors: verma s. Psychol Health Med. 2014;19(1):103-14. doi: 10.1080/13548506.2013.779729. Epub 2013 Apr 23. Psychol Health Med. 2014. PMID: 23607692

5

Canadian women's attitudes towards breast cancer gene testing.

Cappelli M, Surh L, Verma S, Ryan W, Logan D, Korneluk Y, Feeny D, Hunter A, Allanson J. Cappelli M, et al. Among authors: verma s. Am J Hum Genet. 1997 Oct;61(4):A187. Am J Hum Genet. 1997. PMID: 11644962 No abstract available.

6

Living with the BRCA genetic mutation: an uncertain conclusion to an unending process.

DiMillo J, Samson A, Thériault A, Lowry S, Corsini L, Verma S, Tomiak E. DiMillo J, et al. Among authors: verma s. Psychol Health Med. 2013;18(2):125-34. doi: 10.1080/13548506.2012.687827. Epub 2012 Jun 6. Psychol Health Med. 2013. PMID: 22670560

7

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.

Will BP, Le Petit C, Berthelot JM, Tomiak EM, Verma S, Evans WK. Will BP, et al. Among authors: verma s. Br J Cancer. 1999 Mar;79(9-10):1428-36. doi: 10.1038/sj.bjc.6690228. Br J Cancer. 1999. PMID: 10188886 Free PMC article.

8

A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma.

Yau JC, Gertler SZ, Hanson J, Verma S, Grimard LJ, Malik ST, Aref IM, Cross PW, Tomiak EM, Stewart DJ, St Cyr DA, Huan SD. Yau JC, et al. Among authors: verma s. Am J Clin Oncol. 2000 Jun;23(3):292-6. doi: 10.1097/00000421-200006000-00018. Am J Clin Oncol. 2000. PMID: 10857897 Clinical Trial.

9

A model for estimating the costs and burdens of breast cancer diagnosis and treatment in Canada.

Will BP, Berthelot JM, Houle C, Verma S, Tomiak E, Evans WK. Will BP, et al. Among authors: verma s. Health Rep. 1993;5(4):399-408. Health Rep. 1993. PMID: 8011960 English, French.

10

Estimates of the lifetime costs of breast cancer treatment in Canada.

Will BP, Berthelot JM, Le Petit C, Tomiak EM, Verma S, Evans WK. Will BP, et al. Among authors: verma s. Eur J Cancer. 2000 Apr;36(6):724-35. doi: 10.1016/s0959-8049(99)00340-8. Eur J Cancer. 2000. PMID: 10762744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,688 results

Search Page

Filters